Knight Therapeutics Stock
€4.58
Your prediction
Knight Therapeutics Stock
Pros and Cons of Knight Therapeutics in the next few years
Pros
Cons
Performance of Knight Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Knight Therapeutics | 0.440% | 3.153% | 16.837% | 15.075% | 23.118% | 52.667% | 22.460% |
| Biomark Diagnostics Inc. | -6.490% | 0.000% | 1.765% | 123.226% | 25.362% | 246.000% | 24.460% |
| MicroPlanet Technology Corp | 0.680% | 8.029% | -5.128% | 82.266% | -2.632% | 17.460% | -32.110% |
| Avricore Health Inc. | - | 0.000% | -8.000% | 50.000% | 50.000% | -82.487% | -76.531% |
News
EVP of North America's Largest Full Truckload Company EVP Sells All Insider Shares
Michael K Liu, EVP - Operations at Knight-Swift (NYSE:KNX), disposed of 1,243 directly held shares in an open-market sale on Feb. 4, 2026, fully exiting his direct equity position according to a SEC
Changing Your Dog's Diet May Help the Planet More Than Changing Your Own, Study Finds
LONDON, UK / ACCESS Newswire / February 10, 2026 / Diets high in meat, eggs, and dairy products incur significant environmental costs. But a new study has revealed that, in many cases,
One Fund Just Sold $23 Million of This Major Freight Stock. Here's What Investors Should Know
On February 4, Triton Wealth Management, PLLC reported selling 481,779 shares of Knight-Swift Transportation Holdings (NYSE:KNX), an estimated $22.58 million trade based on quarterly average


